Lack of efficacy of a nicotine transdermal treatment on motor and cognitive deficits in Parkinson's disease (Q44701012)

5 December 2017

0 references

Lack of efficacy of a nicotine transdermal treatment on motor and cognitive deficits in Parkinson's disease (English)

1 reference

5 December 2017

1 reference

0 references

Pierre Blanchet

1 reference

5 December 2017

Sylvain Chouinard

1 reference

5 December 2017

Simon Lemay

1 reference

5 December 2017

Hélène Masson

1 reference

5 December 2017

Valérie Soland

1 reference

5 December 2017

Anne Beuter

1 reference

5 December 2017

Marc-André Bédard

1 reference

5 December 2017

publication date

1 January 2004

1 reference

Progress in Neuro-Psychopharmacology & Biological Psychiatry

5 December 2017

published in

1 reference

5 December 2017

1 reference

5 December 2017

1 reference

5 December 2017

page(s)

31-39

1 reference

Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Cigarette smoking and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Beneficial effects of nicotine and cigarette smoking: the real, the possible and the spurious

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Induction of a transient dysexecutive syndrome in Parkinson's disease using a~subclinical dose of scopolamine

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Pharmacology of nicotine: addiction and therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Quantitative Analysis of Rapid Pointing Movements in Cree Subjects Exposed to Mercury and in Subjects with Neurological Deficits

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Analysis of Rapid Alternating Movements in Cree Subjects Exposed to Methylmercury and in Subjects with Neurological Deficits

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

The short-term effect of nicotine chewing gum in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Dissociation of the apparent relationship between nicotine tolerance and up-regulation of nicotinic receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Demonstration of savings on the AVLT and development of a parallel form

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Cholinergic deficiency and frontal dysfunction in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Worsening of motor performance in patients with Parkinson's disease following transdermal nicotine administration

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Nicotine may relieve symptoms of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Smoking and Parkinson's and Alzheimer's disease: review of the epidemiological studies

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Effects of chronic oral nicotine treatment and its withdrawal on locomotor activity and brain monoamines in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Steady-state pharmacokinetics and dose relationship of nicotine delivered from Nicoderm (Nicotine Transdermal System)

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Single- and multiple-dose pharmacokinetics of Nicoderm (Nicotine Transdermal System)

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Parkinsonism: onset, progression, and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Effects of smoking in patients with early-onset Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

In vivo imaging of nicotinic receptor upregulation following chronic (-)-nicotine treatment in baboon using SPECT.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Acute nicotine decreases, and chronic nicotine increases the expression of brain-derived neurotrophic factor mRNA in rat hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Exposure to nicotine enhances the behavioral stimulant effect of nicotine and increases binding of [3H]acetylcholine to nicotinic receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Cortical nicotinic receptors in Alzheimer's disease and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Inter-response interference contributes to the sequencing deficit in frontal lobe lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Cholinergic-dopaminergic interactions in cognitive performance

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Chronic nicotine and withdrawal effects on radial-arm maze performance in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Persistence of chronic nicotine-induced cognitive facilitation

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Chronic nicotine working and reference memory effects in the 16-arm radial maze: interactions with D1 agonist and antagonist drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Motor impairment in PD: relationship to incident dementia and age.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Nicotine prevents experimental parkinsonism in rodents and induces striatal increase of neurotrophic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Unified Parkinson's Disease Rating Scale characteristics and structure. The Cooperative Multicentric Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

The Treatment of Post-Encephalitig Parkinsonism by Nicotine

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Transient Worsening of Parkinson's Disease after Cigarette Smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

The pedunculopontine nucleus and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Nicotine, but not cotinine, partially protects dopaminergic neurons against MPTP-induced degeneration in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Regulation of nicotinic receptors in the brain of mice withdrawn from chronic oral nicotine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Chronic nicotine intake decelerates aging of nigrostriatal dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Nicotinic receptors and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Interrater reliability of the Unified Parkinson's Disease Rating Scale motor examination.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

A postmortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Stimulatory role of dopamine on fibroblast growth factor-2 expression in rat striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflow

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Nicotine stimulation of nerve growth factor receptor expression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Scopolamine reversal of nicotine enhanced delayed matching-to-sample performance in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Transdermal nicotine in PD: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Smoking, nicotine and human performance

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Presynaptic nicotinic receptors modulating dopamine release in the rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

Development and validation of a geriatric depression screening scale: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

A comparison of phonemic, semantic, and alternating word fluency in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

The pedunculopontine nucleus in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900172-6

7 January 2021

10.1016/S0278-5846(03)00172-6

Identifiers

DOI

1 reference

5 December 2017

1 reference